Expanded Access Program With Lenvatinib for the Treatment of Differentiated Thyroid Cancer in Brazil
Clinical trial NCT03533361 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT03533361
- Sponsor
- Eisai Inc.
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.